ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "rheumatoid arthritis (RA) and ultrasound"

  • Abstract Number: 106 • 2012 ACR/ARHP Annual Meeting

    Development of a 6 Joint Simplified Ultrasonographic Score to Assess Disease Activity in Patients with Rheumatoid Arthritis

    Tomas Cazenave1, Christian A. Waimann2, Gustavo Citera1 and Marcos G. Rosemffet1, 1Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 2Rheumatology section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina

    Background/Purpose: Ultrasound has become a routinely available bedside method for the evaluation of patients with Rheumatoid Arthritis (RA). However, it is time consuming, making it…
  • Abstract Number: 2662 • 2012 ACR/ARHP Annual Meeting

    Tightening up: Musculoskeletal Ultrasound Could Further Individualise Treatment Decisions in Early Rheumatoid Arthritis Patients Treated by a Step-up DMARD Escalation Regimen

    James Dale1, David Purves2, Alex McConnachie2, Duncan Porter3 and Iain B. McInnes4, 1Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom, 2Robertson Centre for Biostatistics, University of Glasgow, Glasgow, United Kingdom, 3Rheumatology, Gartnavel General Hospital, Glasgow, United Kingdom, 4Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom

    Background/Purpose: Treat-to-target (T2T) strategies have significantly improved outcomes in early rheumatoid arthritis (RA). Treatment escalation is usually guided by a disease activity score; however, modern…
  • Abstract Number: 1253 • 2012 ACR/ARHP Annual Meeting

    Identifying Vulnerable Plaque in Rheumatoid Arthritis:  A Pilot Study Using Novel Microbubble-Contrast Enhanced Carotid Ultrasonography

    Kimberly P. Liang1, Douglas P. Landsittel2, Suresh R. Mulukutla3, Steven E. Reis4, Marc C. Levesque1, Flordeliza S. Villanueva3, Hunter C. Champion5 and Larry W. Moreland1, 1Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 2Medicine, Biostatistics and Clinical and Translational Science, University of Pittsburgh, Center for Health Care Research Data Center, Pittsburgh, PA, 3Division of Cardiology, University of Pittsburgh, Pittsburgh, PA, 4Division of Cardiology and Department of Clinical and Translational Science, University of Pittsburgh, Pittsburgh, PA, 5Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Rheumatoid arthritis (RA) is independently associated with a higher risk of cardiovascular disease (CVD). Markers of systemic inflammation, as seen in RA, are associated…
  • Abstract Number: 807 • 2012 ACR/ARHP Annual Meeting

    Predictors of Rheumatoid Arthritis: Quantitative and Semiquantitative Sonographic Measurements of Peripheral Joints

    Flavia S. Machado1, Rita N.V. Furtado1, Rogerio D. Takahashi2, Ana Leticia P. de Buosi1 and Jamil Natour1, 1Rheumatology, Universidade Federal de São Paulo, São Paulo, Brazil, 2Radiology, Universidade Federal de São Paulo, São Paulo, Brazil

    Background/Purpose:  Sonographic quantitative and semiquantitative measurements in peripheral joints of normal subjects are yet to be defined, as are sonographic predictors of rheumatoid arthritis (RA).…
  • Abstract Number: 809 • 2012 ACR/ARHP Annual Meeting

    Ultrasonography Predicts Achievement of Deeper Remission After DAS28-Based Clinical Remission of Rheumatoid Arthritis

    Ryusuke Yoshimi1, Maasa Hama1, Daiga Kishimoto1, Reikou Watanabe1, Takeaki Uehara2, Yukiko Asami1, Atsushi Ihata1, Atsuhisa Ueda1, Mitsuhiro Takeno1 and Yoshiaki Ishigatsubo1, 1Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan, 2Department of Rheumatology, Chigasaki Municipal Hospital, Chigasaki, Japan

    Background/Purpose: Although clinical remission is an agreeable goal of treatment in rheumatoid arthritis (RA), the definition is still controversial. Indeed, progressive structural damage is often…
  • Abstract Number: 107 • 2012 ACR/ARHP Annual Meeting

    Sensitivity to Change of the Ultrasound synovitis  SONAR Score in RA Patients : Results of  the Scqm Cohort

    Pascal Zufferey1, Almut Scherer2, Hans Rudolf Ziswiler3, Giorgio Tamborrini4, Laure Brulhart5 and Burkhard Moeller6, 1Service of Rheumatology, Department of Musculoskeletal Medicine, Lausanne University Hospital, Lausanne, Switzerland, 2SCQM Foundation, Zurich, Switzerland, 3Rheumatology, Clinical Immunology and Allergology, Inselspital, University of Bern, Bern, Switzerland, 4Department of Rheumatology, University Hospital, Zurich, Switzerland, 5service de Rhumatologie, Geneva, Switzerland, 6Rheumatology & Clin Immunology, Inselspital Bern, Bern, Switzerland

    Background/Purpose: Since the end of 2009, an ultrasound scoring call SONAR has been implemented for RA patients as a routine tool in the SCQM registry…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology